ViiV Healthcare

#News for #Investors and #Media: Today we shared a press release on real-world research into a long-acting option in #HIV at #IDWeek2026 Find out more 👉 viivhealthcare.com/hiv-news-…

#News for #Investors and #Media: Today we announced we have partnered with Axmed to support access to #HIV medicines in more than 50 middle-income countries. Learn more 👉 viivhealthcare.com/hiv-news-…

#News for #Investors and #Media: Today we announced phase III study results in #HIV evaluating a long-acting option versus daily oral therapy. Learn more 👉 viivhealthcare.com/hiv-news-…

#News for #Media and #Investors: Today we announced a new £9.75 million investment to accelerate the HIV response for paediatrics and adolescents Find out more: viivhealthcare.com/hiv-news-…

#News for #Media and #Investors: Today we announced U.S. FDA approval of an HIV treatment option for young children living with HIV weighing at least 2kg. 👉 Find out more: viivhealthcare.com/hiv-news-…

For the second episode of our #HIV series we explore the evolution of HIV care and the person-centred approaches needed to help people live well and drive progress to end the epidemic. Read the second paid post on The New York Times site: nytimes.com/paidpost/viiv-he…

Tackle HIV takes on Brazil…🏉 At #AIDS2026 in Rio de Janeiro, our @TackleHIV campaign joined inspiring voices like @gareththomas14 and community partners to show how sport, education, visibility and lived experiences can help shift attitudes on #HIV and drive real change. 💪

#News for #Media and #Investors Open Forum Infectious Diseases has published results from a Phase 3 trial investigating an early switch to a long-acting HIV treatment following viral suppression on an oral two-drug regimen. Read more here: doi.org/10.1093/ofid/ofag383

#News for #Investors and #Media: At #AIDS2026 we’re presenting new clinical and real-world insights from across our long-acting portfolio and pipeline across #HIV treatment and prevention. Learn more 👉 viivhealthcare.com/hiv-news-…

#News for #Investors and #Media: At #AIDS2026 we announced new data from the first head-to-head study comparing daily oral 2-drug regimen vs 3-drug regimen in treatment-naïve adults. Find out more 👉 viivhealthcare.com//hiv-news…

#News for #Investors and #Media: Today at #AIDS2026 we announced new findings from a European community co-produced survey highlighting a gap between user interest in long-acting HIV treatments and the clinical conversations taking place. 👉 Read more: viivhealthcare.com/hiv-news-…

#News for #Media and #Investors: We have announced the publication of results from the CLARITY randomized crossover study, comparing single doses of long-acting medicines for HIV prevention. Read the publication on Advances in Therapy here: link.springer.com/article/10… #AIDS2026

#News for #Media and #Investors: We just announced the publication of Week 48 results from a randomised head-to-head study comparing a daily oral 2-drug regimen vs 3-drug regimen in treatment-naïve adults living with HIV. Read more here: gsk.to/4wspjhb

#News for #media and #investors At #AIDS2026, Brazilian Ministry of Health announced they will recommend the inclusion of cabotegravir long-acting for PrEP in their public health system (SUS) ahead of review by CONITEC viivhealthcare.com/hiv-news-…

#News for #Investors and #Media: We’ll be at #AIDS2026 presenting research and insights from our innovative portfolio and INSTI-powered pipeline. Find out more information on our website 👉viivhealthcare.com/hiv-news-…

#News for #Media and #Investors: Today we announced paediatric regulatory progress for one of our HIV treatment options, with marketing applications submitted to the EMA and FDA. 👉 Find out more: viivhealthcare.com

"It's not just about our survival; it's about the quality of life."— Nicoletta Policek. Trust and honest clinician‑patient relationships are essential for people growing older with HIV. Watch Nicoletta explain why shared decision making matters. #WeWontStop

“Ageing with HIV is brilliant because there is so much that we have experienced as a community that we can bring to the new generation.” — Nicoletta Policek, EATG. #WeWontStop #EndingHIV